These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7556725)

  • 1. Regulators of immunological responses in the cornea and the anterior chamber of the eye.
    Jager MJ; Gregerson DS; Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():241-6. PubMed ID: 7556725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas.
    Streilein JW; Bradley D; Sano Y; Sonoda Y
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):413-24. PubMed ID: 8603847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost does not affect immune privilege of corneal allografts.
    Wang M; Kitahara Y; Yoshida A; Hori J
    Exp Eye Res; 2008 Feb; 86(2):394-402. PubMed ID: 18187130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of corneal graft failure in the rat.
    Katami M
    Eye (Lond); 1995; 9 ( Pt 2)():197-207. PubMed ID: 7556718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice.
    Tanaka K; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1827-32. PubMed ID: 10845605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
    Shi W; Xie L; Wang S
    Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
    Hori J; Joyce N; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
    Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.
    Sano Y; Okamoto S; Streilein JW
    Curr Eye Res; 1997 Nov; 16(11):1171-4. PubMed ID: 9395779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cytokine-induced migration of Langerhans cells on corneal allograft survival.
    Niederkorn JY
    Eye (Lond); 1995; 9 ( Pt 2)():215-8. PubMed ID: 7556720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.